| William Richard Colburn, MD | |
|
83 Wellness Way, Benton, KY 42025-7156 | |
| (270) 527-8601 | |
| (270) 527-9615 |
| Full Name | William Richard Colburn |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 83 Wellness Way, Benton, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003834540 | NPI | - | NPPES |
| 64184120 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 18412 (Kentucky) | Primary |
| 208D00000X | General Practice | 18412 (Kentucky) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| William Richard Colburn, MD Po Box 636961, Cincinnati, OH 45263-6961 Ph: (513) 981-5130 | William Richard Colburn, MD 83 Wellness Way, Benton, KY 42025-7156 Ph: (270) 527-8601 |
News Archive
In an article published ahead of print on November 24, 2015 in the journal Diabetes (available at http://dx.doi.org/10.2337/db15-0930), researchers from the Medical University of South Carolina, the American University of Beirut, and Case Western Reserve University report that a molecule called pre-kallikrein (PK) could be a target for the vascular complications associated with type 1 diabetes.
In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, report researchers at Dana-Farber Cancer Institute and affiliated organizations.
Researchers at the Federal University of Rio Grande do Sul, the university hospital (Hospital de Cl-nicas de Porto Alegre, HCPA) and the Children's Cancer Institute (Instituto do C-ncer Infantil do Rio Grande do Sul, ICI-RS) in Porto Alegre, Brazil, have shown that manipulating an epigenetic mechanism, which regulates gene expression, may promote cell death and favor maturation towards less malignant-prone phenotypes in pediatric brain cancer cell lines.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
› Verified 7 days ago
Frances Marie Horn, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 543 Powell Ln, Benton, KY 42025 Phone: 270-415-7070 | |
Austin Beck, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 83 Wellness Way Ste 101&201, Benton, KY 42025 Phone: 270-527-0045 | |
Mr. Edwin Perez-lopez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 83 Wellness Way Ste 101&201, Benton, KY 42025 Phone: 270-527-0045 Fax: 270-527-9615 | |
Kim M Hall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 Old Symsonia Rd, Benton, KY 42025 Phone: 270-527-2411 Fax: 270-527-8734 | |
William Powell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 Old Symsonia Rd, Benton, KY 42025 Phone: 270-527-2411 Fax: 270-527-8734 |